Becker's Hospital Review

August 2021 Issue of Becker's Hospital Review

Issue link: https://beckershealthcare.uberflip.com/i/1393415

Contents of this Issue

Navigation

Page 56 of 95

57 INNOVATION service we provide. Digital endpoints are technologies like online scheduling, asyn- chronous, video visits, voice and application programming interfaces. e combination of AI and these endpoints mean that we can enable more sophisticated navigation, new business models, reduce friction and im- prove care delivery. BJ Moore. Executive Vice President and CIO at Providence (Renton, Wash.). AI is emerging as the most promising technology for healthcare delivery in 2021. ere are sev- eral examples, including ambient AI, which helps our caregivers focus their time and at- tention on patients vs. typing into their EHR. Another example is how predictive modeling helps identify, weeks in advance, surges in diseases like COVID-19, allowing our clini- cians and hospitals to better manage precious resources like PPE, beds and ventilators. Johnese Spisso, RN. President and CEO at UCLA Health (Los Angeles). Telehealth has allowed our physicians and nurses to reach more than half a million patients in the past year during the pandemic. We look forward to continuing to implement advances in tele- medicine offerings at UCLA Health. Ralph Gonzales, MD. Chief Innovation Of- ficer at UCSF Health (San Francisco). e technology that we direly need in 2021 to improve healthcare delivery broadly is EHR data integration so that health records are seamlessly connected across providers and health systems. e technology that looks most promising in 2021 to improve health care delivery is CRIS- PR technology. It's been around a few years, but it's poised to begin making larger impacts on larger numbers of diseases and patients. I'm especially excited about prospects with sickle cell anemia. Ed McCallister. Senior Vice President and CIO at UPMC (Pittsburgh). At UPMC, the most promising technology for healthcare delivery is our continued investment in our enterprise analytics program. is has en- abled us to pair the technology with the data to truly redefine how our clinicians are deliv- ering care to our patients. We have achieved great benefit from this investment during the pandemic with how we are leveraging the data to safely manage the treatment of COVID-19 patients and the delivery of vac- cinations. We envision that the use cases will continue to expand and make an extraordi- nary impact on patient care. Lisa Stump. Senior Vice President and CIO at Yale New Haven (Conn.) Health. Remote patient monitoring and the Internet of Med- ical ings are some of the most promising technologies in healthcare in 2021. ese tools create the opportunity to reenvision and redesign care in a way that meets people where they are, engages them in their care, empowers their health decision-making and promotes their health in a more personal, convenient and cost-effective way. In addi- tion, the data generated through RPM and IoMT opens the door for discovery and fur- ther innovations in healthcare. n Duke Health data chief leaves to head up innovation at Verily's virtual diabetes clinic By Jackie Drees V irtual diabetes clinic Onduo, a Verily company, named Duke Health exec- utive Eric Huang, MD, PhD, its chief science and innovation officer. Dr. Huang most recently served as chief data officer for quality at Duke Health and assistant dean for biomedical informatics at Duke Uni- versity School of Medicine in Durham, N.C. Dr. Huang will lead Onduo's clinical re- search, data collection and real-world evi- dence efforts to help strengthen the compa- ny's Advanced Real-time Cohort engine. The initiative supports population health devel- opments and tools that can deliver person- alized care for patients. Onduo launched as a joint venture with Ver- ily in 2016. The virtual clinic personalizes programs for thousands of members, who all are part of health plans and employer or- ganizations that cover the program costs. n 5 biggest innovation investments health systems made in 2021 By Katie Adams H ealth systems have been pouring investment dollars into digital health startups, research efforts and internal innovation proj- ects throughout 2021, though they often do not disclose the amount. For those that did, below are the five largest innovation invest- ments health systems made in 2021 through June 15. 1. Nationwide Children's Hospital and Ohio State University, both based in Columbus, joined a $1 billion innovation district in Columbus focused on virus, pathogens, stem cell therapies and cancer research. Ohio State will invest $650 million, Nationwide Children's Hospital will invest $350 million and JobsOhio will invest $100 million in the project. 2. Cleveland Clinic is launching an infectious disease research center through a $500 million innovation collaboration with the city of Cleve- land and JobsOhio. Cleveland Clinic will put up $300 million in funds while JobsOhio will invest $200 million. 3. Ascension Ventures, the healthcare venture arm of St. Louis-based As- cension, closed a $285 million strategic venture capital fund, bringing the firm's total assets to more than $1 billion. The fund is backed by 13 health system partners and is Ascension Ventures' fifth venture capital fund. 4. Providence's digital health spinout DexCare closed a $20 million in- vestment round backed by the Renton, Wash.-based health system's innovation arm and Kaiser Permanente Ventures. 5. Rochester, Minn.-based Mayo Clinic led an $8.2 million funding round for TripleBlind, a digital privacy and data sharing platform. n

Articles in this issue

view archives of Becker's Hospital Review - August 2021 Issue of Becker's Hospital Review